New ALS Device Trial; The PARADIGM Study Will Continue Research Of The NeuRx® Diaphragm Pacing System (DPS) In ALS Patients
Synapse Biomedical Inc. (www.synapsebiomedical.com) announced today that it will be rolling out a new ALS trial for its NeuRx Diaphragm Pacing System (DPS). The PARADIGM study will look at the safety and benefit of on-label Humanitarian Device Exemption (HDE) use of the NeuRx DPS® in patients with ALS on non-invasive ventilation (NIV). There have been
Neurostimulation Emerges As An Alternative To Opioids
More Physicians Seek Interventional Therapies for Acute and Chronic Pain; Top Pain Doctors Praise New Peripheral Nerve Stimulation System From SPR Therapeutics; Global Neuromodulation Market to Hit $7 Billion by 2018 Pain physicians in the United States are turning to neurostimulation to treat chronic and acute pain in an effort to combat the opioid epidemic.
Study: Defining High-Growth Companies Is Vital To Success
It may sound like an old proverb, but to understand how high-growth firms contribute to economic prosperity, one must first understand how they are defined. According to a recent study from Cleveland State University Center’s for Economic Development, definitional agreement is vital when examining rapidly growing businesses in Northeast Ohio and across the state. As
Getting Beyond Hiding Your Gender: Paths For Women To Work In Tech
Women who want a career in tech should obscure their gender online, says a provocative Wall Street Journal column. John Greathouse, an investor and serial entrepreneur who teaches at the University of California-Santa Barbara, was writing about the power of online first impressions in hiring. He called many people in the business community “intellectually dishonest,”
Should Women In Tech Hide Their Gender To Get Ahead? JumpStart President Objects On National Stage
Many women saw red on Wednesday after reading a Wall Street Journal advice piece titled “Why Women in Tech Might Consider Just Using Their Initials Online.” Authored by a California-based “investor and serial entrepreneur” named John Greathouse, it urged women seeking tech jobs to “create an online presence that obscures their gender” to compensate for
Hyland President And CEO Bill Priemer Joins 7signal Board Of Directors
7signal, The Wi-Fi Performance Company, announced today that Bill Priemer, President and Chief Executive Officer of Hyland, is joining 7signal’s Board of Directors. Mr. Priemer is an accomplished enterprise software executive with over 25 years of experience in the information and process solutions industry. He joined Hyland in 1997 as Vice President of Marketing becoming
Akron App Developer Emerges As Pathfinder For A Wi-Fi Driven World
An Akron startup wants to let you use its cell phone app to monitor Wi-Fi performance. The software development startup, 7signal, launched the app in July, and already news/entertainment company NBCUniversal is using it, with employees downloading it to their phones. NBCUniversal is “like a lot of companies,” said Jeff Reedy, 7signal’s CEO. “They are
Genomics England To Use GenomOncology’s Knowledge Management System To Analyze Cancer Samples In The 100,000 Genomes Project
Genomics England is partnering with GenomOncology, LLC (GO) to utilize the GO Knowledge Management System (GO KMS) as a tool for clinical reporting enablement. Genomics England will integrate the GO KMS as a key content driver to augment clinical reporting in the 100,000 Genomes Project’s cancer programme, coupling Genomics England curated database with the GO
JumpStart Marketing Director Champions The ‘She’ Of ‘CLE’
JumpStart Inc. partner and marketing director Amy Martin is at the forefront of a venture development organization that in the past decade has injected $35 million into more than 80 tech companies. JumpStart revamped its website last December as part of a new mission statement ensuring entrepreneurs of all racial and social backgrounds have access
JumpStart, Rev1 Work Together To Fund Gene Therapy Developer Milo Biotechnology
A company that aims to help muscular dystrophy patients get stronger has become the first business to get an investment from both JumpStart and Rev1 Ventures. Why is that interesting? JumpStart was founded to help entrepreneurs in the Cleveland area, and Rev1 has a similar mission in Columbus. But in this case, the two state-funded
JumpStart Inc. and Rev1 Ventures Announce Investment in Milo Biotechnology
Cleveland and Columbus Organizations Join Forces to Support Biotech Startup That Uses Gene Therapy to Fight Muscular Dystrophy Cleveland-based venture development organization, JumpStart Inc. and Columbus-based Rev1 Ventures, a top VC investor in the Great Lakes region, have joined together to announce their new investments in Milo Biotechnology, a startup working to reverse Muscular Dystrophy
Securus Medical Raises $10 Million In Round Led By Boston Scientific
Securus Medical Group has raised $10 million in an investment round led by Boston Scientific. The Cleveland company also announced that it has received regulatory clearance that would allow it to begin selling its first product: a temperature-monitoring device intended for use on the esophagus. The money will be used to continue product development and